Rosita Zakaria

Rosita Zakaria

Auto-generated profile, based on publicly available information

Rosita Zakaria

School of Health and Biomedical Sciences, RMIT University , VIC , Australia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016
Verified
Journal Article
Open access
RZRosita Zakaria
Rosita Zakaria
KAKatrina Allen
Katrina Allen
JKJennifer Koplin
Jennifer Koplin
PRPeter Roche
Peter Roche
RGRonda F Greaves
Ronda F Greaves
Through the introduction of advanced analytical techniques and improved throughput, the scope of dried blood spot testing utilising mass spectrometric methods, has broadly expanded. Clinicians and researchers have become very enthusiastic about the potential applications of dried blood spot based mass spectrometric applications. Analysts on the other hand face challenges of sensitivity, reproducibility and overall accuracy of dried blood spot quantification. In this review, we aim to bring together these two facets to discuss the advantages and current challenges of non-newborn screening applications of dried blood spot quantification by mass spectrometry. To address these aims we performed a key word search of the PubMed and MEDLINE online databases in conjunction with individual manual searches to gather information. Keywords for the initial search included; “blood spot” and “mass spectrometry”; while excluding “newborn”; and “neonate”. In addition, databases were restricted to English language and human specific. There was no time period limit applied. As a result of these selection criteria, 194 references were identified for review. For presentation, this information is divided into: 1) clinical applications; and 2) analytical considerations across the total testing process; being pre-analytical, analytical and post-analytical considerations. DBS analysis using MS applications is now broadly applied, with drug monitoring for both therapeutic and toxicological analysis being the most extensively reported. Several parameters can affect the accuracy of DBS measurement and further bridge experiments are required to develop adjustment rules for comparability between dried blood spot measures and the equivalent serum/plasma values. Likewise, the establishment of independent reference intervals for dried blood spot sample matrix is required.

1 June 2014 in Clinical Biochemistry
Verified
Journal Article
Closed access
RZRosita Zakariaeeabkoo
Rosita Zakariaeeabkoo
KAKatrina Allen
Katrina Allen
JKJennifer Koplin
Jennifer Koplin
PVPeter Vuillermin
Peter Vuillermin
RGRonda F Greaves
Ronda F Greaves

1 May 2019 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
RZRosita Zakaria
Rosita Zakaria
KAKatrina Allen
Katrina Allen
JKJennifer Koplin
Jennifer Koplin
PRPeter Roche
Peter Roche
RGRonda F Greaves
Ronda F Greaves
Background: The current millennium has seen an explosion in vitamin D testing with the overarching aim of requests to clinically stratify patients as replete or deficient in vitamin D. At a population level, dried blood spot (DBS) sampling offers a less invasive and more practical application for assessment of vitamin D status. We have therefore aimed to develop a sensitive and robust DBS vitamin D method that is traceable to serum for use in population-based studies. Methods: Blood spots, calibrators and controls were prepared by punching a 3.2 mm DBS from filter paper and placed into a 96-well micro-plate. The DBS disk was eluted with a combination of water-methanol and internal standard (ISTD) solution followed by supported-liquid extraction and derivatisation. The extract was analysed by liquid-chromatography tandem-mass spectrometry in positive electrospray-ionisation mode with 732.5 > 673.4 and 738.4 > 679.4 m/z ion-transitions for derivatised vitamin D and the ISTD, respectively. Vitamin D results were made traceable to the National Institute of Standards and Technology reference material through the inclusion of Chromsystems vitamin D calibrators. Results: 25-Hydroxy-vitamin D3 and its related ISTD were detected at a retention time of 7 min. The seven-point calibration-curve consistently demonstrated a coefficient of determination of 0.99 with an experimentally determined reportable range of 0.5–376 nmol/L. Method validation studies using DBS samples demonstrated 12.9% between-assay imprecision at 45 nmol/L, 84% average recovery and high correlation with plasma vitamin D (correlation coefficient = 0.86). Conclusions: We have successfully developed an analytical method for vitamin D quantitation from DBSs which will be applied to our population-based vitamin D research study. This approach improves traceability of DBS results and potentially could be used broadly for other DBS measurands that require comparison to serum/plasma for their interpretation.

29 April 2025 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Open access
MHMd. Munnaf Hossen
Md. Munnaf Hossen
Bobbi FleissBobbi Fleiss
Bobbi Fleiss
RZRosita Zakaria
Rosita Zakaria
Kynurenine pathway (KP) metabolites are implicated in various disorders, including Alzheimer's disease, schizophrenia, and adverse pregnancy outcomes. Simultaneous measurement of multiple KP metabolites offers valuable insight into the pathway's role in health and disease, would improve this relatively undeveloped field. This systematic review aim was to summarize the state of the art for measuring the eight key KP metabolites, using liquid chromatography-mass spectrometry (LC-MS), explicitly focusing on whether methods were validated using established guidelines with superior sensitivity and selectivity. We undertook a comprehensive review of the literature using the PRISMA guidelines. Our search uncovered 66 publications, and 39 qualified the defined key criteria. We summarized each publication's method development parameters, analytical design, and method performance specifications. We found notable variability in sample preparation techniques and analytical design across biological matrices, underscoring a lack of universally established and validated methods for KP metabolite quantification. We also identified significant gaps in the basic method evaluation. Our findings highlight that no single method has been evaluated for quantifying the eight key KP metabolites across three or more biological sample types, revealing a critical gap in the field. Our review emphasizes the need for robust analytical methods to quantify KP metabolites across multiple biological matrices, facilitating a better understanding of their roles in health and disease. Given the diversity of disorders involving the KP in the clinical testing lab, developing such methods will reduce diagnostic errors and advance KP metabolite research, supporting more precise, and personalized medical care.

7 June 2019 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
RZRosita Zakaria
Rosita Zakaria
RGRonda F Greaves
Ronda F Greaves
Article The re-emergence of dried blood spot sampling – are we ready? was published on December 1, 2019 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 57, issue 12).

1 November 2021 in Clinical Biochemistry
Verified
Journal Article
Closed access
CTCarlie Tuddenham
Carlie Tuddenham
RGRonda F Greaves
Ronda F Greaves
ARAnushi E. Rajapaksa
Anushi E. Rajapaksa
JWJohn D. Wark
John D. Wark
RZRosita Zakaria
Rosita Zakaria